SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (547)1/6/2003 11:15:22 AM
From: Jibacoa  Read Replies (1) of 7424
 
AMEV 25% ? Make that 42.29% <g>

It got some help from JP Morgan's analyst Jeffrey Zekauskas, who raised his rating to "overweight" from "underweight".<g>(And of course some of the recent gain has also to do with the fact that it has been selling below book and it has $2.48 in cash/share as well as some products in its pipeline.<g>)

I have AMEV in my entry list (up 80% since Dec.31 and getting now a little overbought.<g>)

DYAX may have some help from the C.C. at 10AM tomorrow. It is selling around book, at 0.9 of sales and should do better when it gets over its Dec, 11 H of $2.23 (that was an up-day with pretty good volume of 377.6K <g>)

RAGL

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext